MedPath

Oocyte Donor Application Discrepancies

Completed
Conditions
Infertility
Registration Number
NCT06362551
Lead Sponsor
Inception Fertility Research Institute, LLC
Brief Summary

Retrospective observational study comparing information received on Inception Central Donor Recruitment's standardized online egg donor application compared to information reported during a Genetic Risk Assessment (GRA) consultation with a certified genetic counselor with contracted third party genetic counseling service, GeneScreen. All donor applicants completing a full application with Inception's Central Donor Recruitment and a GRA consultation with GeneScreen will be included.

Detailed Description

Background: Historically, it has been considered sufficient to have an egg donor applicant complete a written application that is reviewed by an egg donor program for acceptability. In 2021, ASRM put forth recommendations that "family history review and assessment of donors should be performed by a certified genetic counselor". In 2022, Inception Central Donor Recruitment (CDR) established a process for screening donor applicants that included Genetic Risk Assessment (GRA) with a certified genetic counselor. This study seeks to illustrate the discrepancies between personal and family history information documented on a standardized online application compared to a GRA consultation with a certified genetic counselor.

Objectives: Investigate the rate of new information obtained at GRA which was not included in the full application, as follows:

* New information with no change to health risk assessment (i.e. change in number of relatives)

* New information with a change to health risk assessment (i.e. known or suspected diagnoses for OD or family), with one of the following decisions

* Still acceptable/approved for clinic (ie new multifactorial condition reported, such as diabetes)

* Decline based on TPN internal guidelines alone (ie meets NCCN criteria for genetic testing)

* Decline based on ASRM guidelines (ie first degree relative with a major malformation)

Hypothesis: Information obtained through GRA with a certified genetic counselor will lead to more detailed and accurate assessment of donor applicant eligibility. Some information obtained through GRA, which was not apparent on application, will lead to a donor applicant being declined based on internal Prelude Network Donor Screening Guidelines and/or guidelines set forth by the American Society of Reproductive Medicine.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • All oocyte donor applicants completing a full application with Inception's Central Donor Recruitment and a GRA consultation with GeneScreen will be included.
Exclusion Criteria
  • Not applicable

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of additional information6 months

Simple statistical calculations will be evaluated for rate of additional information identified.

Rate of applicant decline6 months

Simple statistical calculations will be evaluated for rate of applicant decline based on new information.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Inception Fertility LLC

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath